Latest Financial Position News

Patronus Resources reports significant drilling progress across its Western Australia and Northern Territory projects, with strong assay results at Mertondale and a robust cash position supporting ongoing exploration.

Lotus Resources has fast-tracked the restart of its Kayelekera uranium project in Malawi, targeting production by Q3 2025, backed by a $132 million capital raise. Meanwhile, its Letlhakane project in Botswana reports a 65% increase in measured and indicated uranium resources.

OD6 Metals reports a transformative quarter with the acquisition of the historic Gulf Creek Copper Project revealing high-grade copper assays, alongside promising metallurgical advances at its Splinter Rock rare earths project. The company enters 2025 with strong cash reserves and active exploration programs.

Imagion Biosystems has secured a AU$3 million capital injection and resumed its collaboration with Siemens, setting the stage to prioritize FDA filings and advance its MagSense® HER2 breast cancer imaging program.

Austral Gold reported an 8.5% production increase in Q4 2024 alongside significant cost reductions, though full-year output fell short of forecasts due to equipment delays. The company sets ambitious 2025 targets, supported by a new toll processing deal and plant refurbishment financing.

AusQuest Limited has announced a significant porphyry copper-gold discovery at its Cangallo Project in Peru, marking a potential turning point ahead of an active 2025 exploration calendar. The company also secured $2.4 million in funding to advance drilling programs across its Peru and Australian assets.

Buxton Resources reports robust drilling results at its Graphite Bull and Narryer projects, completes Stage 1 earn-in on Copper Wolf JV with IGO, and undertakes key board changes, positioning itself for an active 2025 exploration season.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Uvre Limited has completed a key Phase 2 geophysical survey at its Frome Downs Uranium Project in South Australia and secured a Heritage Survey Agreement, setting the stage for its inaugural drilling program.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Sovereign Metals has delivered an Optimised Prefeasibility Study reaffirming Kasiya’s status as a globally significant rutile and graphite project, alongside advancing rehabilitation efforts and positive graphite test results.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.